Aperio Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.25M | Buy |
13,730
+3,732
| +37% | +$339K | ﹤0.01% | 1461 |
|
|
2020
Q3 | $400K | Buy |
9,998
+1,987
| +25% | +$79.5K | ﹤0.01% | 1937 |
|
|
2020
Q2 | $275K | Buy |
+8,011
| New | +$275K | ﹤0.01% | 2064 |
|
|
2019
Q3 | – | Sell |
-3,911
| Closed | -$79K | – | 2460 |
|
|
2019
Q2 | $79K | Buy |
+3,911
| New | +$79K | ﹤0.01% | 2448 |
|